Counterpoint Mutual Funds’s Agilon Health AGL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$273K Buy
+3,433
New +$334K 0.02% 244
2025
Q2
– Sell
-7,396
Closed -$801K – 305
2025
Q1
$801K Buy
+7,396
New +$644K 0.11% 70
2024
Q4
– Sell
-13,323
Closed -$1.31M – 281
2024
Q3
$1.31M Buy
13,323
+10,485
+369% +$1.35M 0.25% 14
2024
Q2
$464K Buy
2,838
+76
+3% +$10.8K 0.11% 61
2024
Q1
$421K Buy
+2,762
New +$460K 0.1% 44

Other funds holding AGL

Counterpoint Mutual Funds's AGL Position: Q3 2026 in Review

Counterpoint Mutual Funds opened a new position in Agilon Health (AGL) in Q3 2026: 3,433 shares worth $273K. The stake represents 0.02% of the portfolio and ranks #244 among its holdings. This is a return to the name: Counterpoint Mutual Funds previously reported a position in AGL as recently as Q1 2025.

Counterpoint Mutual Funds first reported a position in AGL in Q1 2024 and has held it in 5 quarters since. The position peaked at $1.31M in Q3 2024. 180 funds tracked by Wall St. Rank hold AGL as of Q3 2026.

  • Counterpoint Mutual Funds held 3,433 shares of Agilon Health worth $273K as of Q3 2026.
  • Agilon Health was a new Counterpoint Mutual Funds position in Q3 2026.
  • Agilon Health made up 0.02% of Counterpoint Mutual Funds's portfolio in Q3 2026, its #244 holding.
  • Counterpoint Mutual Funds first reported a position in Agilon Health in Q1 2024 and has held it in 5 quarters since.
  • Counterpoint Mutual Funds's Agilon Health position peaked at $1.31M in Q3 2024.
  • 180 funds tracked by Wall St. Rank held Agilon Health as of Q3 2026.

Based on Counterpoint Mutual Funds's 13F filing for Q3 2026, filed 16 Oct 2026.